Study of the effects of bromocriptine on sexual impotence

B. Ambrosi, R. Bara, P. Travaglini, G. Weber, P. Beck Peccoz, M. Rondena, R. Elli, G. Faglia

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Serum testosterone, prolactin, LH, FSH and plasma 17β-oestradiol levels were determined in forty-seven male patients with sexual impotence. Low testosterone values and slightly elevated prolactin levels were observed in 19% and 17% of cases, respectively. Since sexual function in the male seems to be controlled by both dopaminergic stimulatory and serotoninergic inhibitory mechanisms, bromocriptine was given orally to seventeen patients. As the preliminary results appeared encouraging, double blind study was undertaken in the other thirty patients. No appreciable difference in hormonal pattern was noted between bromocriptine and placebo treatment. As far as sexual function was concerned, good results were obtained in 52% of cases treated with bromocriptine and in 44% of patients given placebo.

Original languageEnglish
Pages (from-to)417-421
Number of pages5
JournalClinical Endocrinology
Volume7
Issue number5
Publication statusPublished - 1977

Fingerprint

Bromocriptine
Erectile Dysfunction
Prolactin
Testosterone
Placebos
Double-Blind Method
Estradiol
Serum
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Ambrosi, B., Bara, R., Travaglini, P., Weber, G., Beck Peccoz, P., Rondena, M., ... Faglia, G. (1977). Study of the effects of bromocriptine on sexual impotence. Clinical Endocrinology, 7(5), 417-421.

Study of the effects of bromocriptine on sexual impotence. / Ambrosi, B.; Bara, R.; Travaglini, P.; Weber, G.; Beck Peccoz, P.; Rondena, M.; Elli, R.; Faglia, G.

In: Clinical Endocrinology, Vol. 7, No. 5, 1977, p. 417-421.

Research output: Contribution to journalArticle

Ambrosi, B, Bara, R, Travaglini, P, Weber, G, Beck Peccoz, P, Rondena, M, Elli, R & Faglia, G 1977, 'Study of the effects of bromocriptine on sexual impotence', Clinical Endocrinology, vol. 7, no. 5, pp. 417-421.
Ambrosi B, Bara R, Travaglini P, Weber G, Beck Peccoz P, Rondena M et al. Study of the effects of bromocriptine on sexual impotence. Clinical Endocrinology. 1977;7(5):417-421.
Ambrosi, B. ; Bara, R. ; Travaglini, P. ; Weber, G. ; Beck Peccoz, P. ; Rondena, M. ; Elli, R. ; Faglia, G. / Study of the effects of bromocriptine on sexual impotence. In: Clinical Endocrinology. 1977 ; Vol. 7, No. 5. pp. 417-421.
@article{bdfce0f2379d499cb85b4bdd151596e8,
title = "Study of the effects of bromocriptine on sexual impotence",
abstract = "Serum testosterone, prolactin, LH, FSH and plasma 17β-oestradiol levels were determined in forty-seven male patients with sexual impotence. Low testosterone values and slightly elevated prolactin levels were observed in 19{\%} and 17{\%} of cases, respectively. Since sexual function in the male seems to be controlled by both dopaminergic stimulatory and serotoninergic inhibitory mechanisms, bromocriptine was given orally to seventeen patients. As the preliminary results appeared encouraging, double blind study was undertaken in the other thirty patients. No appreciable difference in hormonal pattern was noted between bromocriptine and placebo treatment. As far as sexual function was concerned, good results were obtained in 52{\%} of cases treated with bromocriptine and in 44{\%} of patients given placebo.",
author = "B. Ambrosi and R. Bara and P. Travaglini and G. Weber and {Beck Peccoz}, P. and M. Rondena and R. Elli and G. Faglia",
year = "1977",
language = "English",
volume = "7",
pages = "417--421",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Study of the effects of bromocriptine on sexual impotence

AU - Ambrosi, B.

AU - Bara, R.

AU - Travaglini, P.

AU - Weber, G.

AU - Beck Peccoz, P.

AU - Rondena, M.

AU - Elli, R.

AU - Faglia, G.

PY - 1977

Y1 - 1977

N2 - Serum testosterone, prolactin, LH, FSH and plasma 17β-oestradiol levels were determined in forty-seven male patients with sexual impotence. Low testosterone values and slightly elevated prolactin levels were observed in 19% and 17% of cases, respectively. Since sexual function in the male seems to be controlled by both dopaminergic stimulatory and serotoninergic inhibitory mechanisms, bromocriptine was given orally to seventeen patients. As the preliminary results appeared encouraging, double blind study was undertaken in the other thirty patients. No appreciable difference in hormonal pattern was noted between bromocriptine and placebo treatment. As far as sexual function was concerned, good results were obtained in 52% of cases treated with bromocriptine and in 44% of patients given placebo.

AB - Serum testosterone, prolactin, LH, FSH and plasma 17β-oestradiol levels were determined in forty-seven male patients with sexual impotence. Low testosterone values and slightly elevated prolactin levels were observed in 19% and 17% of cases, respectively. Since sexual function in the male seems to be controlled by both dopaminergic stimulatory and serotoninergic inhibitory mechanisms, bromocriptine was given orally to seventeen patients. As the preliminary results appeared encouraging, double blind study was undertaken in the other thirty patients. No appreciable difference in hormonal pattern was noted between bromocriptine and placebo treatment. As far as sexual function was concerned, good results were obtained in 52% of cases treated with bromocriptine and in 44% of patients given placebo.

UR - http://www.scopus.com/inward/record.url?scp=0017724681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017724681&partnerID=8YFLogxK

M3 - Article

C2 - 338206

AN - SCOPUS:0017724681

VL - 7

SP - 417

EP - 421

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 5

ER -